Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
12 months ago
By
In Biopharma ManufacturingInnovationLeadersPharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer
12 months ago
By
In Biopharma ManufacturingBreakthroughsClinical TrialsFDA ApprovalsIndustry ConferencesInnovationLeadersResearch UpdatesVenture Capital
June Pharma Highlights: Vaccine Panel Shake-up, Moderna Deal Fallout, and FDA’s AI Adoption
1 year ago
By
In Featured AnalysisInnovationLeadersPharma Industry Updates
Major Biotech M&A and Global Partnerships Drive Mid-Year Industry Realignment
1 year ago
By
In DealsInnovationLeadersPartnershipsPharma Industry UpdatesResearch Updates
Hillchol Oral Cholera Vaccine Shows Promise in Phase III Trial in India
1 year ago
By
In Clinical TrialsInnovationLeaders
Trodelvy plus Keytruda Shows Promise in First-Line PD-L1+ Triple-Negative Breast Cancer
1 year ago
By
In Clinical TrialsInnovationLeaders
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
By
In InvestmentsLeadersPartnerships
MAIA Biotechnology Sets Its Sights on Bold Cancer Immunotherapy Milestones for 2025
1 year ago
By
In Breaking NewsFDA ApprovalsLeadersResearch UpdatesTop Stories
FDA Leadership Change Sparks Industry Concern as Pharma Navigates Regulatory Challenges
1 year ago
By
In Biopharma HighlightsInnovationLeadersPharma Industry Updates
EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders
1 year ago
By
In Breaking NewsLeaders
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
1 year ago
By
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
1 year ago
By
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage
1 year ago
By
In Industry ConferencesLeadersPeople
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos
1 year ago
By
In DealsLeadersResearch Updates
FDA Approves First Oral Therapy for Severe Eczema in Adolescents
1 year ago
By
In Biopharma HighlightsBreaking NewsFDA ApprovalsLeaders
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January
1 year ago
By
In Biopharma HighlightsBreakthroughsDealsFunding RoundsLeadersVenture Capital
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy
1 year ago
By
In AI & DataClinical TrialsInnovationLeaders
GSK’s Jemperli Receives EMA Approval for First-Line Endometrial Cancer Treatment
1 year ago
By
In Clinical TrialsFeatured AnalysisLeadersPharma Industry Updates
FDA Approves Datopotamab Deruxtecan (Datroway) for HR-Positive, HER2-Negative Breast Cancer
1 year ago
By
In FDA ApprovalsInnovationLeadersResearch Updates
Denali, Agios, Cabaletta and Walden Drive Rare Disease and Immuno-Innovations into the Spotlight at JP Morgan Week
1 year ago
By
In Breaking NewsBreakthroughsIndustry ConferencesLeadersPeopleTop Stories
NHS Launches World-First AI Tool to Predict Type 2 Diabetes Risk From ECG Readings
1 year ago
By
In InnovationLeaders
FDA Awards RMAT Designation to Mesoblast’s Cell Therapy for Heart Defect, Paving the Way for Pediatric Innovation
1 year ago
By
In Biopharma HighlightsFDA ApprovalsLeadersPharma Industry UpdatesTop Stories
Pragmatic Trials, Real-World Impact: NIH’s 2024 Push to Redefine Clinical Research
1 year ago
By
In BreakthroughsFeatured AnalysisLeadersTop Stories
Atezolizumab Shows Promise in Rare Thyroid Cancer: Roche’s Immunotherapy Gains Ground in RET-Altered Tumors
1 year ago
By
In Clinical TrialsLeadersResearch Updates
Driving Innovation and Navigating Complexity in 2024
2 years ago
By
In Leaders